Alzamend Neuro Inc.

13F holders, Q4 2024 (December 31)
17holders +5
7new positions
3sold out
2famous investors
$1.16avg. 13F price*

At the end of Q4 2024, 17 institutions reported holding Alzamend Neuro Inc. in their 13F filings, up 5 from Q3 2024. 7 opened new positions and 3 sold out. The largest holders were Geode Capital Management, LLC ($39K), Citadel Advisors ($36K) and Truist Financial Corp. ($18K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Alzamend Neuro Inc.
CUSIP
02262M506
Latest filing quarter
Q1 2025

History

Number of 13F holders

05101520 Q2 2024: 2Q2 2024Q3 2024: 12Q3 2024Q4 2024: 17Q4 2024Q1 2025: 11Q1 2025

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions7$108K
Exits3$31K

All 13F filers, Q3 2024 → Q4 2024: 93,298 shares bought and 22,088 shares sold, net +71,210 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 17 holders

Geode Capital Management, LLC 0.00% New 33,540 $39K
Citadel Advisors 0.00% New 30,638 $36K
Truist Financial Corp. 0.00% No change 15,498 $18K
Renaissance Technologies 0.00% New 15,000 $17K
Virtu Financial LLC 0.00% New 12,719 $15K
BlackRock, Inc. 0.00% No change 3,973 $5K
UBS Group AG 0.00% New 820 $951
Citigroup Inc. 0.00% New 544 $631
Tower Research Capital LLC (TRC) 0.00% Reduce -90.7% 388 $450
Bank of America Corp. 0.00% Add +29.5% 136 $158
Harbor Investment Advisory, LLC 0.00% No change 20 $23
Activest Wealth Management 0.00% No change 20 $23
SBI Securities Co., Ltd. 0.00% — 18 $21
Osaic Holdings, Inc. 0.00% New 6 $7
City State Bank 0.00% No change 4 $5
Morgan Stanley 0.00% No change 3 $3
Parallel Advisors, LLC 0.00% No change 3 $3

"% of holder's portfolio" is ALZAMEND NEURO INC's weight in each manager's 13F, not the share of Alzamend Neuro Inc. the manager owns.